View in EDS

Cost-effectiveness and return on investment of 20-valent pneumococcal conjugate vaccine use among adults in England: analysis from the societal perspective.

Saved in:
Bibliographic Details
Title: Cost-effectiveness and return on investment of 20-valent pneumococcal conjugate vaccine use among adults in England: analysis from the societal perspective.
Authors: Mendes D; Pfizer Ltd., Tadworth, UK. Diana.Mendes@pfizer.com., Averin A; Avalere Health, Washington, DC, USA., Atwood M; Avalere Health, Washington, DC, USA., Sato R; Pfizer Inc., Collegeville, PA, USA., Vyse A; Pfizer Ltd., Tadworth, UK., Campling J; Pfizer Ltd., Tadworth, UK., Hariharan D; Avalere Health, Washington, DC, USA., Weycker D; Avalere Health, Washington, DC, USA., Mugwagwa T; Pfizer Ltd., Tadworth, UK., Vietri J; Pfizer Inc., Collegeville, PA, USA.
Source: Cost effectiveness and resource allocation : C/E [Cost Eff Resour Alloc] 2026 Jan 21; Vol. 24 (1), pp. 31. Date of Electronic Publication: 2026 Jan 21.
Publication Type: Journal Article
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101170476 Publication Model: Electronic Cited Medium: Print ISSN: 1478-7547 (Print) Linking ISSN: 14787547 NLM ISO Abbreviation: Cost Eff Resour Alloc Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41566327
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Cost-effectiveness and return on investment of 20-valent pneumococcal conjugate vaccine use among adults in England: analysis from the societal perspective.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Mendes+D%22">Mendes D</searchLink>; Pfizer Ltd., Tadworth, UK. Diana.Mendes@pfizer.com.<br /><searchLink fieldCode="AU" term="%22Averin+A%22">Averin A</searchLink>; Avalere Health, Washington, DC, USA.<br /><searchLink fieldCode="AU" term="%22Atwood+M%22">Atwood M</searchLink>; Avalere Health, Washington, DC, USA.<br /><searchLink fieldCode="AU" term="%22Sato+R%22">Sato R</searchLink>; Pfizer Inc., Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Vyse+A%22">Vyse A</searchLink>; Pfizer Ltd., Tadworth, UK.<br /><searchLink fieldCode="AU" term="%22Campling+J%22">Campling J</searchLink>; Pfizer Ltd., Tadworth, UK.<br /><searchLink fieldCode="AU" term="%22Hariharan+D%22">Hariharan D</searchLink>; Avalere Health, Washington, DC, USA.<br /><searchLink fieldCode="AU" term="%22Weycker+D%22">Weycker D</searchLink>; Avalere Health, Washington, DC, USA.<br /><searchLink fieldCode="AU" term="%22Mugwagwa+T%22">Mugwagwa T</searchLink>; Pfizer Ltd., Tadworth, UK.<br /><searchLink fieldCode="AU" term="%22Vietri+J%22">Vietri J</searchLink>; Pfizer Inc., Collegeville, PA, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101170476%22">Cost effectiveness and resource allocation : C/E</searchLink> [Cost Eff Resour Alloc] 2026 Jan 21; Vol. 24 (1), pp. 31. <i>Date of Electronic Publication: </i>2026 Jan 21.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101170476 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>1478-7547 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214787547%22">14787547 </searchLink><i>NLM ISO Abbreviation: </i>Cost Eff Resour Alloc <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41566327
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s12962-025-00709-6
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 31
    Titles:
      – TitleFull: Cost-effectiveness and return on investment of 20-valent pneumococcal conjugate vaccine use among adults in England: analysis from the societal perspective.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Mendes D
      – PersonEntity:
          Name:
            NameFull: Averin A
      – PersonEntity:
          Name:
            NameFull: Atwood M
      – PersonEntity:
          Name:
            NameFull: Sato R
      – PersonEntity:
          Name:
            NameFull: Vyse A
      – PersonEntity:
          Name:
            NameFull: Campling J
      – PersonEntity:
          Name:
            NameFull: Hariharan D
      – PersonEntity:
          Name:
            NameFull: Weycker D
      – PersonEntity:
          Name:
            NameFull: Mugwagwa T
      – PersonEntity:
          Name:
            NameFull: Vietri J
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 21
              M: 01
              Text: 2026 Jan 21
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 1478-7547
          Numbering:
            – Type: volume
              Value: 24
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Cost effectiveness and resource allocation : C/E
              Type: main
ResultId 1